Patrick Burnett Arcutis Biotherapeutics, Inc. (ARQT) insider trading activity

Patrick Burnett is Officer of Arcutis Biotherapeutics, Inc.. Currently has a direct ownership of 98,307 shares of ARQT, which is worth approximately $2.46 Million. The most recent transaction as insider was on Dec 15, 2025, when has been sold 11,500 shares (Common Stock) at a price of $28.94 per share, resulting in proceeds of $332,810. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 98.3K

6.21% 3M change

23.6% 12M change

Total Value Held $2.46 Million

Patrick Burnett Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 15 2025	SELL Open market or private sale	$332,810 $28.94 p/Share	11,500 Reduced 10.47%	98,307 Common Stock
Dec 15 2025	BUY Exercise of conversion of derivative security	$41,860 $3.64 p/Share	11,500 Added 9.48%	109,807 Common Stock
Nov 06 2025	SELL Open market or private sale	$417,105 $24.18 p/Share	17,250 Reduced 14.93%	98,325 Common Stock
Nov 06 2025	BUY Exercise of conversion of derivative security	$62,790 $3.64 p/Share	17,250 Added 12.99%	115,575 Common Stock
Nov 05 2025	SELL Open market or private sale	$91,654 $23.72 p/Share	3,864 Reduced 3.78%	98,325 Common Stock
Nov 03 2025	SELL Open market or private sale	$65,681 $25.05 p/Share	2,622 Reduced 2.5%	102,189 Common Stock
Aug 21 2025	SELL Open market or private sale	$37,959 $15.57 p/Share	2,438 Reduced 2.27%	104,811 Common Stock

Aug 19 2025	SELL Open market or private sale	$28,280 $16.16 p/Share	1,750 Reduced 1.61%	107,249 Common Stock
Aug 08 2025	SELL Open market or private sale	$53,973 $14.03 p/Share	3,847 Reduced 3.41%	108,999 Common Stock
Aug 04 2025	SELL Open market or private sale	$37,573 $14.33 p/Share	2,622 Reduced 2.27%	112,846 Common Stock
Jul 14 2025	SELL Open market or private sale	$86,652 $15.07 p/Share	5,750 Reduced 4.74%	115,468 Common Stock
Jul 14 2025	BUY Exercise of conversion of derivative security	-	5,750 Added 4.53%	121,218 Common Stock
Jul 10 2025	SELL Open market or private sale	$346,150 $15.05 p/Share	23,000 Reduced 16.61%	115,468 Common Stock
Jul 10 2025	BUY Exercise of conversion of derivative security	-	23,000 Added 14.24%	138,468 Common Stock
May 08 2025	SELL Open market or private sale	$52,606 $13.59 p/Share	3,871 Reduced 3.24%	115,468 Common Stock
May 02 2025	SELL Open market or private sale	$39,448 $15.19 p/Share	2,597 Reduced 2.13%	119,339 Common Stock
Mar 14 2025	SELL Open market or private sale	$184,119 $15.04 p/Share	12,242 Reduced 9.12%	121,936 Common Stock
Mar 14 2025	BUY Exercise of conversion of derivative security	-	12,242 Added 8.36%	134,178 Common Stock
Mar 13 2025	SELL Open market or private sale	$739,381 $15.04 p/Share	49,161 Reduced 28.73%	121,936 Common Stock
Mar 13 2025	BUY Exercise of conversion of derivative security	-	5,008 Added 3.8%	126,944 Common Stock
Mar 04 2025	SELL Open market or private sale	$12,669 $13.28 p/Share	954 Reduced 0.57%	166,089 Common Stock
Mar 03 2025	SELL Open market or private sale	$36,731 $13.03 p/Share	2,819 Reduced 1.66%	167,043 Common Stock
Feb 28 2025	BUY Grant, award, or other acquisition	-	55,000 Added 24.46%	169,862 Common Stock
Feb 03 2025	SELL Open market or private sale	$153,873 $12.7 p/Share	12,116 Reduced 9.54%	114,862 Common Stock
Dec 31 2024	SELL Open market or private sale	$23,674 $14.0 p/Share	1,691 Reduced 1.31%	126,978 Common Stock

Patrick Burnett

Officer

Westlake Village, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ARQT shares.

Notify only if

Value

Insider Trading

Get notified when an Arcutis Biotherapeutics, Inc. insider buys or sells ARQT shares.

Notify only if

Operation

Value

Type

News

Receive news related to Arcutis Biotherapeutics, Inc.

Track Activities on ARQT

Account